• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGILE ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGILE ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00517630
Device Problems Use of Device Problem (1670); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/07/2022
Event Type  malfunction  
Event Description
It was reported to boston scientific corporation on february 01, 2022 that an agile esophageal fully covered rmv stent was implanted in the duodenum to treat benign pancreatitis during a procedure performed on (b)(6) 2021.Two weeks post stent placement, the stent had migrated into the stomach.Reportedly, the stent remains implanted.No patient complications were reported as a result of this event.The patient was reported to be fully recovered.Note: it was reported that the agile esophageal fully covered stent was implanted in the duodenum for benign pancreatitis.Per the ifu, "the agile esophageal fully covered rmv stent system is intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, occlusion of concurrent esophageal fistulas and treating refractory benign esophageal strictures." the stent is not indicated to be implanted in the duodenum.Note: boston scientific has been unable to obtain additional information regarding the event to date, despite good faith efforts.
 
Manufacturer Narrative
Approximated 2 weeks after the implant date.(b)(4).The complainant indicated that stent remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Manufacturer Narrative
Approximated 2 weeks after the implant date.(b)(4).The complainant indicated that stent remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on february 01, 2022 that an agile esophageal fully covered rmv stent was implanted in the duodenum to treat benign pancreatitis during a procedure performed on (b)(6) 2021.Two weeks post stent placement, the stent had migrated into the stomach.Reportedly, the stent remains implanted.No patient complications were reported as a result of this event.The patient was reported to be fully recovered.Note: it was reported that the agile esophageal fully covered stent was implanted in the duodenum for benign pancreatitis.Per the ifu, "the agile esophageal fully covered rmv stent system is intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, occlusion of concurrent esophageal fistulas and treating refractory benign esophageal strictures." the stent is not indicated to be implanted in the duodenum.Note: boston scientific has been unable to obtain additional information regarding the event to date, despite good faith efforts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGILE ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13590730
MDR Text Key286069495
Report Number3005099803-2022-00938
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2023
Device Model NumberM00517630
Device Catalogue Number1763
Device Lot Number0027718698
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/23/2021
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
-
-